Founded in 2012 and based in Los Osos, California, I-V Access Technology is a private medical device company dedicated to revolutionizing venous access for patients and clinicians. The company's core mission is to enhance the venous access experience through innovative solutions. Their flagship product, VENAGLIDE, aims to improve the efficiency and success rate of catheter insertions. The company also offers other products like VenaValve® and VenaSave®, focusing on reducing vascular access device failure, a common issue in hospital settings.

I-V Access Technology has garnered attention for its innovative approach to vascular access, attracting interest from key figures in the medical device industry. While specific notable affiliated people and investors are not detailed, the company's impact is evident through its commitment to solving pervasive issues in venous access. With over 350 million peripheral IV catheters sold annually in the US, their advancements promise significant improvements in patient care and clinical outcomes, positioning them as a transformative player in the medical device market.